Butacit
Generic Name
Butamirate Citrate
Manufacturer
Square Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| butacit 5 mg pediatric drop | ৳ 50.00 | N/A |
Description
Overview of the medicine
Butacit 5 mg Pediatric Drop is a cough suppressant medication containing Butamirate Citrate. It is used for the symptomatic treatment of non-productive cough in children. It helps to relieve dry cough by acting on the cough center in the brain.
Uses & Indications
Dosage
Adults
Not recommended for adults; specific adult formulations are available if needed.
Elderly
Not typically used for elderly; adult formulations might be considered if appropriate.
Renal_impairment
No specific dose adjustment necessary for mild to moderate renal impairment, but caution advised in severe cases.
How to Take
Administer orally using the dropper provided. Can be taken with or without food. Ensure proper measurement of drops.
Mechanism of Action
Butamirate Citrate acts centrally on the cough center in the brain, selectively inhibiting the cough reflex without depressing the respiratory center. It also has bronchodilatory and anti-inflammatory effects.
Pharmacokinetics
Onset
Within 30 minutes to 1 hour.
Excretion
Mainly excreted by the kidneys, primarily as metabolites.
Half life
Approximately 4-6 hours.
Absorption
Rapidly and completely absorbed after oral administration.
Metabolism
Undergoes hydrolysis to two metabolites, 2-phenylbutyric acid and diethylaminoethoxyethanol, which also possess antitussive activity. Metabolized in the liver.
Side Effects
Contraindications
- Hypersensitivity to Butamirate Citrate or any component of the formulation
- Productive cough (where mucus needs to be expelled)
- Children under 1 year of age
Drug Interactions
CNS depressants
Concomitant use with CNS depressants (e.g., alcohol, sedatives, hypnotics) may enhance their sedative effects.
Expectorants/Mucolytics
Avoid concurrent use with expectorants or mucolytics as Butamirate's antitussive action may lead to retention of bronchial secretions, increasing the risk of bronchospasm and respiratory tract infections.
Storage
Store below 30°C, in a dry place, protected from light. Keep out of reach of children.
Overdose
Symptoms of overdose may include drowsiness, nausea, vomiting, diarrhea, dizziness, and hypotension. Treatment is symptomatic and supportive; gastric lavage may be considered if recent ingestion. Naloxone is not an antidote.
Pregnancy & Lactation
Not recommended during the first trimester of pregnancy. Use in second and third trimesters and during lactation only if potential benefits outweigh risks, and under medical supervision. Consult a doctor.
Side Effects
Contraindications
- Hypersensitivity to Butamirate Citrate or any component of the formulation
- Productive cough (where mucus needs to be expelled)
- Children under 1 year of age
Drug Interactions
CNS depressants
Concomitant use with CNS depressants (e.g., alcohol, sedatives, hypnotics) may enhance their sedative effects.
Expectorants/Mucolytics
Avoid concurrent use with expectorants or mucolytics as Butamirate's antitussive action may lead to retention of bronchial secretions, increasing the risk of bronchospasm and respiratory tract infections.
Storage
Store below 30°C, in a dry place, protected from light. Keep out of reach of children.
Overdose
Symptoms of overdose may include drowsiness, nausea, vomiting, diarrhea, dizziness, and hypotension. Treatment is symptomatic and supportive; gastric lavage may be considered if recent ingestion. Naloxone is not an antidote.
Pregnancy & Lactation
Not recommended during the first trimester of pregnancy. Use in second and third trimesters and during lactation only if potential benefits outweigh risks, and under medical supervision. Consult a doctor.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
24 months from manufacturing date (unopened)
Availability
Pharmacies, drugstores
Approval Status
Approved by DGDA
Patent Status
Off-patent
Clinical Trials
Butamirate Citrate has been evaluated in various clinical trials demonstrating its efficacy and safety in cough suppression, particularly in pediatric populations. Further studies may explore specific long-term effects or comparative efficacy.
Lab Monitoring
- No specific routine lab monitoring required for typical use.
Doctor Notes
- Emphasize proper dosing with dropper for children.
- Advise against concurrent use with expectorants/mucolytics.
- Educate parents on signs of worsening cough or respiratory distress requiring immediate medical attention.
Patient Guidelines
- Use the provided dropper for accurate dosing.
- Do not exceed the recommended dose.
- If cough persists for more than 7 days, worsens, or is accompanied by fever, rash, or persistent headache, consult a doctor.
- Keep out of reach of children.
Missed Dose Advice
If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose.
Driving Precautions
May cause drowsiness or dizziness. Patients should be advised to avoid driving or operating machinery if they experience these effects.
Lifestyle Advice
- Ensure adequate hydration to help soothe the throat.
- Avoid irritants like smoke and dust.
- Maintain good hygiene to prevent spread of infection.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine. Click a brand to search for detailed information.
Other Medicines in Butacit Brand
Other medicines available under the same brand name
